3月17日，上美股份（02145）发布公告，近期公司与苏州开拓药业股份有限公司签订了化妆品领域附带排他条款的战略合作框架协议，主要涉及美白祛斑功效性化妆品原料KT-939的快速商业化。
此次合作旨在加速KT-939的注册及相关产品的市场推出，进一步丰富公司的产品线布局，并提升在化妆品前沿原料及产品效用的科学研究壁垒。
根据公告，双方将协同推进KT-939在中国的注册和产品开发，以实现化妆品成分与产品的同步上市。此次合作预计将加强国货美白原料及产品的市场竞争力，并促进公司的持续发展与稳健成长。
值得注意的是，KT-939及相关产品尚未获得相关监管机构的最终审批，实际审批结果及时间仍存在不确定性。公司提醒股东及潜在投资者在买卖证券时需谨慎行事。
（文章来源：财中社）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.